Medical system for seamless therapy adjustment

Abstract

Methods and systems for seamless adjustment of treatment are disclosed. A determination is made as to whether to intervene with a patient's treatment. Implanted device memory data is acquired over a pre-specified time period. Risk status is determined from the device memory data. Another external device memory data is acquired over a pre-specified time period. A determination is made as to whether to adjust treatment of the patient in response to the risk status, the data acquired from the implanted device memory and the external device memory data.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application claims the benefit of U.S. Provisional Application No. 62 / 301,313, filed on Feb. 29, 2016 and US Provisional Application No. 62 / 435,181 filed on Dec. 17, 2016. The disclosure of the above applications are incorporated herein by reference in their entirety.TECHNICAL FIELD[0002]The present disclosure relates to a medical system, and, more particularly, to a medical system configured to determine whether to intervene with a patient's treatment.BACKGROUND[0003]Chronic heart failure (CHF) is a serious condition that occurs when a heart is unable to consistently pump blood at an adequate rate. To improve the ability of the heart to pump blood, CHF patients may require an implantable medical device (IMD). IMDs such as implantable cardioverter defibrillators (ICDs) or pacemakers are capable of delivering cardiac resynchronization therapy for improving a CHF patient's heart function. Despite using IMDs to improve heart function, C...

AI Technical Summary

Benefits of technology

[0009]The present disclosure achieves numerous benefits over conventional healthcare systems. For example, the healthcare system is configured to adjust therapy without directly contacting the physician immediately and / or in real-time before adjusting the therapy. By adjusting therapy without first contacting the physician, time spent by the physician, the patient and the patient's caretaker are reduced compared to conventional health care systems that requires the patient to physically visit the doctor whenever the patient's diuretics require adjustment. Additionally, the patient will be administered the proper medication in a more timely fashion thereby reducing or avoiding worsening HF condition.

Problems solved by technology

Despite using IMDs to improve heart function, CHF patients may progressively deteriorate, as evidenced by weight gain, change in blood pressure, malaise, fatigue, swelling, fainting, and / or palpitations.

Images